Shape Therapeutics

Gary Fortin, Chief Operating Officer

Oct. 11 | 2:00pm | Rentschler ATMP Ballroom 

Seattle, WA  


ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions